Cure My Disease

Don't miss your cure!

 Log in / Sign up

New pill could help blood disorder patients when standard care fails

NCT ID NCT07007962

Recruiting now Disease control Sponsor: Sanofi Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests an oral drug called rilzabrutinib in adults with immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding risks. Participants must have failed first-line treatment. The goal is to see if the drug can raise platelet counts to safer levels. About 60 people will take the drug for up to 28 weeks, with some continuing longer.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IMMUNE THROMBOCYTOPENIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Purpura, Thrombocytopenic, Idiopathic thrombocytopenia due to immune destruction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

IMMUNE THROMBOCYTOPENIA

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Beth Israel Deaconess Medical Center

    RECRUITING

    Boston, Massachusetts, 02215, United States

  • Community Cancer Trials of Utah-Investigational Site Number: 8400002

    RECRUITING

    Ogden, Utah, 84405, United States

  • Community Health Partners (CHP) - Community Medical Oncology Specialists (University Oncology Associates)

    RECRUITING

    Clovis, California, 93611, United States

  • Investigational Site Number : 0400001

    RECRUITING

    Vienna, 1140, Austria

  • Investigational Site Number : 2030002

    RECRUITING

    Prague, 12800, Czechia

  • Investigational Site Number : 2500001

    RECRUITING

    Dijon, 21079, France

  • Investigational Site Number : 2500002

    RECRUITING

    Pessac, 33604, France

  • Investigational Site Number : 2500004

    RECRUITING

    Toulouse, 31059, France

  • Investigational Site Number : 2760004

    RECRUITING

    Leipzig, 04103, Germany

  • Investigational Site Number : 3480001

    RECRUITING

    Budapest, Hungary

  • Investigational Site Number : 3480002

    RECRUITING

    Kaposvár, 7400, Hungary

  • Investigational Site Number : 3800002

    RECRUITING

    Meldola, Italy

  • Investigational Site Number : 3800003

    RECRUITING

    Vicenza, 36100, Italy

  • Investigational Site Number : 3800004

    RECRUITING

    Milan, 20162, Italy

  • Investigational Site Number : 3800006

    RECRUITING

    Naples, 80131, Italy

  • Investigational Site Number : 3800007

    RECRUITING

    Torino, 10126, Italy

  • Investigational Site Number : 6160002

    RECRUITING

    Gdansk, 80-219, Poland

  • Investigational Site Number : 6160003

    RECRUITING

    Skorzewo, 60-185, Poland

  • Investigational Site Number : 6160004

    RECRUITING

    Słupsk, 76-200, Poland

  • Investigational Site Number : 7240001

    RECRUITING

    Barcelona, 8003, Spain

  • Investigational Site Number : 7240002

    RECRUITING

    Burgos, 9006, Spain

  • Investigational Site Number : 7240003

    RECRUITING

    San Cristóbal de La Laguna, Spain

  • Investigational Site Number : 7240004

    RECRUITING

    Seville, 41013, Spain

  • Investigational Site Number : 7240005

    RECRUITING

    Murcia, 30008, Spain

  • Investigational Site Number : 7240007

    RECRUITING

    Madrid, 28007, Spain

  • Investigational Site Number : 7240008

    RECRUITING

    Madrid, 28046, Spain

  • Investigational Site Number: 2500003

    RECRUITING

    Créteil, 94000, France

  • Mass General Brigham Cancer Institute

    RECRUITING

    Danvers, Massachusetts, 01923, United States

  • Massachusetts General Hospital Cancer Center

    RECRUITING

    Boston, Massachusetts, 02114, United States

  • Mayo Clinic_Investigational Site Number: 8400009

    RECRUITING

    Rochester, Minnesota, 55905, United States

  • Montefiore Medical Center-Investigational Site Number: 8400012

    RECRUITING

    The Bronx, New York, 10467, United States

  • New York Oncology Hematology-Investigational Site Number: 8400010

    RECRUITING

    Albany, New York, 12208, United States

  • Oregon Health and Sciences University

    RECRUITING

    Portland, Oregon, 97239, United States

  • Tulane University Health Sciences Center - Tulane Avenue-Investigational Site Number: 8400011

    RECRUITING

    New Orleans, Louisiana, 70112, United States

  • University of Michigan Health - Michigan Medicine - University Hospital-Investigational Site Number: 8400001

    RECRUITING

    Ann Arbor, Michigan, 48109, United States

  • University of Southern California (USC)

    RECRUITING

    Los Angeles, California, 90089, United States